NCT03343327View on ClinicalTrials.gov

A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 19, 2018

Primary Completion Date

April 20, 2018

Study Completion Date

April 20, 2018

Conditions
Adrenal Insufficiency
Interventions
DRUG

Chronocort®

Single dose of 20mg Chronocort® administered in one treatment period

DRUG

Cortef®

Single dose of 20mg Cortef® administered in one treatment period

Trial Locations (1)

CF48 4DR

Simbec Research Ltd., Merthyr Tydfil

Sponsors
All Listed Sponsors
collaborator

Simbec Research

INDUSTRY

collaborator

Brush Clinical Research Ltd.

INDUSTRY

collaborator

Voet Consulting

INDUSTRY

collaborator

Bionical Emas Ltd.

UNKNOWN

collaborator

Medical Matters International Ltd

INDUSTRY

lead

Neurocrine UK Limited

INDUSTRY